Promising cure for rare lung cancer

September 27, 2014 4:59 PM

10 0

Scientists have found a new use for Pfizer’s Xalkori drug that holds promise of a cure for a rare lung cancer.

A study conducted by Dr. Alice Shaw and colleagues from Massachusetts General Hospital Cancer Center in Boston has shown the efficacy of Pfizer’s drug Xalkori, chemically known as crizotinib in reducing tumours in non-small cell lung cancers (NSCLC). The drug targets patients with a specific gene mu...

Read more

To category page